ABT Q2 2015 report in Norwegian ABT Q2 2015 presentation ABT Q2 2015 press releaseAqua Bio Technology ASA (Oslo Axess: ABT) today announced the second quarter 2015 financial results. Revenues were in line with previously announced contracts and saw a strong growth from the second quarter last year. Also the Company's profitability improved significantly. The combined results in the two first quarters of 2015 make the first half of 2015 ABT's best first half year ever.
Aqua Bio Technology had revenues of NOK 9.0 million in the second quarter, up from NOK 5.2 million in the corresponding quarter last year. EBITDA for the quarter ended at NOK 4.7 million, representing an EBITDA margin of 52.2 per cent. Last year's EBITDA of NOK -0.2 million was adversely affected by a legal dispute in the United States. ABTs net result for the second quarter 2015 was NOK 3.2 million, compared to NOK -1.7 million last year.
For the first half of 2015 ABT had revenues of NOK 18.1 million, up from NOK 10.6 million in the first six months of last year. EBITDA for the first half was NOK 10.0 million, compared to NOK 1.0 million last year. The first half's net result ended at NOK 7.3 million, against NOK -2.1 million last year.
"We enjoy a strong financial position and have a transparent revenue stream the next couple of years. On this basis we are now looking to expand our business through establishing partnerships with other bio technology companies, and leverage from our sales and marketing expertise," said Aqua Bio Technology's CEO Arvid Lindberg.
For further information, please call Arvid Lindberg, CEO, telephone +47 9824 5410
Aqua Bio Technology (ABT) has launched several cosmetic ingredients to the global skincare market. The ingredient, based on the Company's unique, marine technology and other technologies, have documented positive effects on the skin. Skin care is the fastest growing segment in the cosmetics industry, where ABT's ingredients have established a foothold. In addition to ingredients from its own technology, ABT also commercializes technologies/ingredients for partners, for use in novel skin care products. Aqua Bio Technology i listed on the Axess market of the Oslo Stock Exchange.